Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Cuppen

Showing results (271-280 of 287) with videos related to

Pageof 29
Sort By:
Scientific Reports|December 15, 2020
Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct diseaseMonique M A Verstegen, Floris J M Roos, Ksenia Burka, et al.
Nature Genetics|May 22, 2012
Dominant missense mutations in ABCC9 cause Cantú syndromeMagdalena Harakalova, Jeske J T van Harssel, Paulien A Terhal, et al.
Nature Protocols|December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceKris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Genome Research|April 18, 2015
Characteristics of de novo structural changes in the human genomeWigard P Kloosterman, Laurent C Francioli, Fereydoun Hormozdiari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided TreatmentLouisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, et al.
Annals of Clinical and Translational Neurology|January 16, 2015
Identification of Srp9 as a febrile seizure susceptibility geneEllen V S Hessel, Marina de Wit, Inge G Wolterink-Donselaar, et al.
Nature Genetics|April 30, 2008
SNP and haplotype mapping for genetic analysis in the rat, Kathrin Saar, Alfred Beck, et al.
Nature|September 1, 2022
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
European Journal of Human Genetics : EJHG|August 14, 2015
Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effectsTerry Vrijenhoek, Ken Kraaijeveld, Martin Elferink, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
Pageof 29

Showing results (271-280 of 287) with videos related to

Sort By:
Pageof 29
Scientific Reports|December 15, 2020
Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct diseaseMonique M A Verstegen, Floris J M Roos, Ksenia Burka, et al.
Nature Genetics|May 22, 2012
Dominant missense mutations in ABCC9 cause Cantú syndromeMagdalena Harakalova, Jeske J T van Harssel, Paulien A Terhal, et al.
Nature Protocols|December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceKris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Genome Research|April 18, 2015
Characteristics of de novo structural changes in the human genomeWigard P Kloosterman, Laurent C Francioli, Fereydoun Hormozdiari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided TreatmentLouisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, et al.
Annals of Clinical and Translational Neurology|January 16, 2015
Identification of Srp9 as a febrile seizure susceptibility geneEllen V S Hessel, Marina de Wit, Inge G Wolterink-Donselaar, et al.
Nature Genetics|April 30, 2008
SNP and haplotype mapping for genetic analysis in the rat, Kathrin Saar, Alfred Beck, et al.
Nature|September 1, 2022
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
European Journal of Human Genetics : EJHG|August 14, 2015
Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effectsTerry Vrijenhoek, Ken Kraaijeveld, Martin Elferink, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
Pageof 29